MedTrace Logo

Hartmann's Solution and Normal Saline in Type II Diabetes Patients

NCT02305199 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-04-20

No results posted yet for this study

Summary

The purpose of this study is to determine whether perioperative use of Hartmann's solution in type II diabetes patients increases blood glucose level after surgery. The investigators expect the result to broaden the choice of fluid for diabetic patients and hopefully to diminish the side effects manifested by the excess use of normal saline.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

Hartmann's solution

Hartmann's solution containing 200 mg/L of calcium chloride, 300 mg/L of potassium chloride, 6 g/L of Sodium chloride, 3.1 g/L of Sodium lactate.

DRUG

Normal saline

Fluid containing Sodium chloride 9 g/L

Sponsors & Collaborators

  • Yeungnam University College of Medicine

    lead OTHER

Principal Investigators

  • Sung Mee Jung, MD · Yeungnam University College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2017-04-01
Completion
2017-04-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02305199 on ClinicalTrials.gov